Long-Term Proton Pump Inhibitor Use: Review of Indications and Special Considerations.

Clin Gastroenterol Hepatol

Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California.

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2024.01.042DOI Listing

Publication Analysis

Top Keywords

long-term proton
4
proton pump
4
pump inhibitor
4
inhibitor review
4
review indications
4
indications special
4
special considerations
4
long-term
1
pump
1
inhibitor
1

Similar Publications

Proton pump inhibitors and all-cause mortality risk among cancer patients.

World J Clin Oncol

January 2025

Department of Supportive Oncology, Atrium Health Levine Cancer, Charlotte, NC 28204, United States.

Background: Proton pump inhibitors (PPIs) are widely used, including among cancer patients, to manage gastroesophageal reflux and other gastric acid-related disorders. Recent evidence suggests associations between long-term PPI use and higher risks for various adverse health outcomes, including greater mortality.

Aim: To investigate the association between PPI use and all-cause mortality among cancer patients by a comprehensive analysis after adjustment for various confounders and a robust methodological approach to minimize bias.

View Article and Find Full Text PDF

Background: Apart from massive weight loss, metabolic and bariatric surgery, especially gastric bypass (Roux-en-Y gastric bypass [RYGB]), can cause nutritional deficiencies. Proton pump inhibitors (PPI), relatively often used after RYGB, are associated with reduced calcium absorption. We have studied the long-term impact of PPI upon calcium homeostasis among RYGB patients.

View Article and Find Full Text PDF

Gastroesophageal reflux disease (GERD) affects millions globally, with traditional treatments like proton pump inhibitors (PPIs) and surgical fundoplication presenting challenges such as long-term medication dependency and disturbing long term side effects following surgery. This review explores emerging, alternative therapies that offer less invasive, personalized alternatives for GERD management. Endoscopic approaches, including Stretta therapy, transoral incisionless fundoplication (TIF), and endoscopic full-thickness plication (EFTP), demonstrate promising but also controversial outcomes in symptom relief and reduced acid exposure.

View Article and Find Full Text PDF

Proton Beam Therapy for Advanced Periocular Skin Cancer: An Eye-Sparing Approach.

Cancers (Basel)

January 2025

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Cox 308, Boston, MA 02114, USA.

The management of periocular skin malignancies presents a unique challenge. Proton beam therapy, due to its sharp dose fall-off, allows for the delivery of a tumoricidal dose to the tumor while sparing adjacent normal tissues. Thirteen patients with a median age of 76.

View Article and Find Full Text PDF

Proton pump inhibitor use and all-cause mortality in stroke survivors on antiplatelet therapy: An NHANES analysis.

J Clin Neurosci

January 2025

Department of Neurology, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, Guangdong, China. Electronic address:

Introduction: Stroke is a leading cause of death and disability worldwide. Antiplatelet therapy is essential for preventing ischemic stroke recurrence, but it carries a risk of gastrointestinal (GI) bleeding. Proton pump inhibitors (PPIs) are often prescribed to mitigate this risk, but their long-term use has been linked to increased all-cause mortality.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!